Literature DB >> 10627691

Triple arthrodesis.

P T Fortin1, A K Walling.   

Abstract

Twenty-five adult patients with 32 fused hind-feet were evaluated at an average of 4.3 years after triple arthrodesis. All patients had Stage 3 or 4 deformity secondary to adult acquired flatfoot. All operations were performed using a standardized technique using rigid internal fixation. Postoperative American Orthopaedic Foot and Ankle Society hindfoot scores improved an average of 36 points. There was one nonunion and two residual varus malunions in patients who underwent additional procedures to obtain satisfactory position and fusion. All but one patient were satisfied with the result of their procedures and would have surgery again. With careful attention given to positioning, a triple arthrodesis is an acceptable treatment for late stage deformities in patients with adult acquired flatfoot.

Entities:  

Mesh:

Year:  1999        PMID: 10627691     DOI: 10.1097/00003086-199908000-00012

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

1.  Surgical Management of Symptomatic Adult Pes Planovalgus Secondary to Stage 2B Posterior Tibial Tendon Dysfunction: A Comparison of Two Different Surgical Treatments.

Authors:  Christopher Fang Junxian; Remesh Kunnasegaran; Gowreeson Thevendran
Journal:  Indian J Orthop       Date:  2020-01-24       Impact factor: 1.251

Review 2.  Adult-Acquired Flatfoot Deformity.

Authors:  Jensen K Henry; Rachel Shakked; Scott J Ellis
Journal:  Foot Ankle Orthop       Date:  2019-01-16

3.  Double versus triple arthrodesis for adult-acquired flatfoot deformity due to stage III posterior tibial tendon insufficiency: a prospective comparative study of two cohorts.

Authors:  Amr A Fadle; Wael El-Adly; Ahmed Khalil Attia; Mo'men M Mohamed; Aly Mohamadean; Ahmed E Osman
Journal:  Int Orthop       Date:  2021-04-25       Impact factor: 3.075

4.  Adult rigid flatfoot: Triple arthrodesis and osteotomy.

Authors:  Zongyu Yang; Fei Liu; Liang Cui; Heda Liu; Junshui Zuo; Lin Liu; Sentian Li
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.